Related Experiment Videos
Inflammatory breast cancer: advances in therapy
L M Ellis1, K I Bland, E M Copeland
1Department of Surgery, University of Florida College of Medicine, Gainesville 32610.
Seminars in Surgical Oncology
|January 1, 1988
Summary
Inflammatory breast cancer is an aggressive neoplasm often diagnosed clinically. Aggressive combined therapy, including chemotherapy, surgery, and irradiation, is crucial for improving survival rates in this systemic disease.
Area of Science:
- Oncology
- Medical Research
Background:
- Inflammatory breast cancer (IBC) is the most aggressive form of breast cancer.
- It presents with distinct clinical characteristics, often allowing for clinical diagnosis.
- Dermal lymphatic invasion may be present on biopsy, but its absence does not preclude aggressive treatment.
Purpose of the Study:
- To summarize the diagnostic and therapeutic considerations for inflammatory breast cancer.
- To emphasize the systemic nature of this disease and the need for comprehensive treatment strategies.
Main Methods:
- Clinical diagnosis based on characteristic presentation.
- Biopsy for histopathological confirmation, including assessment of dermal lymphatic invasion.
- Review of treatment outcomes for various therapeutic modalities.
Main Results:
- Surgery or irradiation alone has limited impact on the natural history of IBC.
- Lymphatic invasion and distant metastases are frequently observed at initial presentation.
- Aggressive combined modality therapy has shown to prolong disease-free and overall survival.
Conclusions:
- Inflammatory breast cancer must be viewed as a systemic disease.
- A multi-modal treatment approach incorporating chemotherapy, surgery, and irradiation is essential.
- Combined modality therapy offers improved survival outcomes for patients with IBC.